Total Payments
$1,921
2024 Payments
$660.90
Companies
10
Transactions
20
Medicare Patients
6,441
Medicare Billing
$4.2M
Payment Breakdown by Category
Food & Beverage$1,728 (90.0%)
Travel$192.61 (10.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,728 | 19 | 90.0% |
| Travel and Lodging | $192.61 | 1 | 10.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $480.98 | 5 | $0 (2024) |
| Alcon Vision LLC | $417.55 | 2 | $0 (2024) |
| Genentech, Inc. | $277.58 | 4 | $0 (2018) |
| Medtronic Vascular, Inc. | $212.63 | 3 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $118.15 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $106.38 | 1 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $97.50 | 1 | $0 (2022) |
| Allergan Inc. | $92.26 | 1 | $0 (2018) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $70.96 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $46.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $660.90 | 4 | Alcon Vision LLC ($417.55) |
| 2023 | $106.38 | 1 | Astellas Pharma US Inc ($106.38) |
| 2022 | $97.50 | 1 | Regeneron Healthcare Solutions, Inc. ($97.50) |
| 2019 | $526.26 | 6 | Genentech USA, Inc. ($242.67) |
| 2018 | $435.34 | 6 | Genentech, Inc. ($183.18) |
| 2017 | $94.40 | 2 | Genentech, Inc. ($94.40) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2024 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $224.94 | General |
| Category: Ophthalmology | ||||||
| 11/16/2024 | Alcon Vision LLC | — | Travel and Lodging | In-kind items and services | $192.61 | General |
| Category: Ophthalmology | ||||||
| 11/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $125.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/11/2024 | Regeneron Pharmaceuticals, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $118.15 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/27/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $106.38 | General |
| 11/10/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $97.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/13/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $94.75 | General |
| Category: Ophthalmology | ||||||
| 07/18/2019 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $147.92 | General |
| Category: Ophthalmology | ||||||
| 05/16/2019 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $103.01 | General |
| Category: Stents | ||||||
| 05/13/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE ONE DAY (Device) | Food and Beverage | In-kind items and services | $70.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/27/2019 | Medtronic Vascular, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $49.70 | General |
| Category: Transcatheter Valve Systems | ||||||
| 02/07/2019 | Medtronic Vascular, Inc. | TRAcelet (Device) | Food and Beverage | In-kind items and services | $59.92 | General |
| Category: Transradial | ||||||
| 11/05/2018 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $114.55 | General |
| Category: Ophthalmology | ||||||
| 10/11/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $80.47 | General |
| Category: Ophthalmology | ||||||
| 07/26/2018 | Novartis Pharmaceuticals Corporation | BROLUCIZUMAB (Drug) | Food and Beverage | In-kind items and services | $46.79 | General |
| 07/21/2018 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: Ophthalmology | ||||||
| 03/08/2018 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $92.26 | General |
| Category: RETINA | ||||||
| 02/12/2018 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $68.63 | General |
| Category: Ophthalmology | ||||||
| 09/25/2017 | Genentech, Inc. | Lucentis (Biological), Non-Covered Product | Food and Beverage | In-kind items and services | $56.00 | General |
| Category: Ophthalmology | ||||||
| 06/06/2017 | Genentech, Inc. | Non-Covered Product (Drug) | Food and Beverage | In-kind items and services | $38.40 | General |
| Category: None | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,632 | 12,968 | $3.0M | $1.2M |
| 2022 | 12 | 1,583 | 5,080 | $2.4M | $1.0M |
| 2021 | 13 | 1,615 | 4,905 | $2.3M | $956,643 |
| 2020 | 12 | 1,611 | 5,227 | $2.4M | $1.0M |
Total Patients
6,441
Total Services
28,180
Medicare Billing
$4.2M
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 94 | 876 | $1.3M | $606,456 | 46.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 29 | 7,380 | $442,800 | $214,246 | 48.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 269 | 1,115 | $398,730 | $109,758 | 27.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 27 | 535 | $321,000 | $96,556 | 30.1% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 161 | 708 | $106,200 | $51,595 | 48.6% |
| 92134 | Imaging of retina | Office | 2023 | 444 | 1,416 | $155,543 | $43,287 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 305 | 621 | $134,190 | $40,250 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 88 | $27,555 | $8,618 | 31.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 59 | 59 | $23,510 | $6,024 | 25.6% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 63 | 63 | $21,030 | $5,533 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $16,340 | $4,484 | 27.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 33 | 34 | $14,365 | $3,766 | 26.2% |
| 92250 | Photography of the retina | Office | 2023 | 35 | 35 | $5,150 | $967.00 | 18.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 107 | 896 | $1.3M | $644,557 | 48.0% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 28 | 579 | $347,400 | $128,296 | 36.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 283 | 973 | $318,870 | $93,093 | 29.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 172 | 580 | $87,000 | $42,020 | 48.3% |
| 92134 | Imaging of retina | Office | 2022 | 426 | 1,198 | $131,700 | $36,804 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 269 | 538 | $102,220 | $34,810 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 78 | $21,840 | $7,171 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $23,650 | $7,010 | 29.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 47 | 47 | $18,659 | $4,953 | 26.5% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 35 | 35 | $15,755 | $3,542 | 22.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 38 | 38 | $12,616 | $3,334 | 26.4% |
| 92250 | Photography of the retina | Office | 2022 | 60 | 63 | $9,825 | $1,668 | 17.0% |
About Dr. Apurva Patel, MD
Dr. Apurva Patel, MD is a Ophthalmology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1073770707.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Apurva Patel, MD has received a total of $1,921 in payments from pharmaceutical and medical device companies, with $660.90 received in 2024. These payments were reported across 20 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,728).
As a Medicare-enrolled provider, Patel has provided services to 6,441 Medicare beneficiaries, totaling 28,180 services with total Medicare billing of $4.2M. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology, Retina Specialist
- Location Portland, OR
- Active Since 05/20/2008
- Last Updated 10/01/2024
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1073770707
Products in Payments
- Lucentis (Biological) $594.96
- Vabysmo (Drug) $125.20
- EYLEA HD (Biological) $118.15
- Resolute (Device) $103.01
- EYLEA (Biological) $97.50
- OZURDEX (Drug) $92.26
- BIOTRUE ONE DAY (Device) $70.96
- TRAcelet (Device) $59.92
- CoreValve Evolut (Device) $49.70
- BROLUCIZUMAB (Drug) $46.79
- Non-Covered Product (Drug) $38.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Portland
James Rosenbaum, M.d, M.D
Ophthalmology — Payments: $293,531
Ophthalmology $293,531
Dr. Mark Pennesi, Md Phd, MD PHD
Ophthalmology — Payments: $185,243
Ophthalmology $185,243
Peter Francis, Md, MD
Ophthalmology — Payments: $156,902
Ophthalmology $156,902
Roger Dailey, Md, MD
Ophthalmology — Payments: $135,004
Ophthalmology $135,004
Dr. Brian Chan-Kai, M.d, M.D
Ophthalmology — Payments: $123,899
Ophthalmology $123,899
Dr. Mark Terry, Md, MD
Ophthalmology — Payments: $112,572
Ophthalmology $112,572